Effects of primary and secondary low‐grade respiratory syncytial virus infections in a murine model of asthma
- 4 August 2004
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 34 (8) , 1307-1313
- https://doi.org/10.1111/j.1365-2222.2004.02033.x
Abstract
Background Respiratory syncytial virus (RSV) infection is known to develop and exacerbate asthma in young children. In adult, RSV causes recurrent but asymptomatic infections. However, the impact of asymptomatic RSV infection on adult asthma is yet to be determined. The present study is designed to determine the effects of primary and secondary low‐grade RSV infections on allergic airway inflammation in a murine model of allergic asthma. Methods A low‐grade RSV (2 × 103 plaque‐forming units/mouse) was inoculated, and this caused neither pulmonary inflammation nor symptoms but induced significant IFN‐γ production in thoracic lymph nodes. To investigate interaction between low‐grade virus and Dermatophagoides farinae (Df), airway hyper‐responsiveness, lung inflammation and cytokine production from thoracic lymph nodes were compared after primary and secondary low‐grade RSV infections in four groups of mice; control, Df allergen‐sensitized, RSV‐infected and Df‐sensitized RSV‐infected mice. A direct comparison between low‐ and high‐grade RSV infections was also performed in primary infection. To investigate the role of IL‐5 during secondary RSV infection, anti‐IL‐5 monoclonal antibody (anti‐IL‐5 mAb) was injected in mice and similar parameters were compared in four groups of mice. Results Primary high‐grade RSV infection increased allergen‐induced airway inflammation, while primary low‐grade RSV infection attenuated allergen‐induced airway inflammation concomitant with significant IFN‐γ production in lung‐draining lymph nodes. In marked contrast, secondary low‐grade RSV infection increased both IFN‐γ and IL‐5 production, resulting in exacerbation of allergen‐induced airway inflammation. Anti‐IL‐5 mAb treatment in secondary low‐grade RSV infection and Df allergen‐sensitized mice attenuated virus and allergen‐induced airway inflammation. Conclusions Low‐grade RSV infection per se does not cause pulmonary inflammation, whereas it induces a significant immunological response in the allergen‐sensitized host. These results indicate that subclinical and recurrent RSV infection may play an important role in exacerbation and maintenance of asthma in adults, wherein IL‐5 is critically involved.Keywords
This publication has 35 references indexed in Scilit:
- Differences in Participation of Innate and Adaptive Immunity to Respiratory Syncytial Virus in Adults and NeonatesThe Journal of Infectious Diseases, 2003
- Cytokine and Chemokine Gene Expression after Primary and Secondary Respiratory Syncytial Virus Infection in Cotton RatsThe Journal of Infectious Diseases, 2002
- Immunostimulatory DNA sequences inhibit respiratory syncytial viral load, airway inflammation, and mucus secretionJournal of Allergy and Clinical Immunology, 2001
- Long-term consequences of respiratory syncytial virus (RSV) bronchiolitisPaediatric Respiratory Reviews, 2000
- Respiratory Syncytial Virus Infection in AdultsClinical Microbiology Reviews, 2000
- Respiratory syncytial virus infectionThe Lancet, 1999
- Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.Journal of Clinical Investigation, 1997
- Interleukin-5 Expression in the Lung Epithelium of Transgenic Mice Leads to Pulmonary Changes Pathognomonic of AsthmaThe Journal of Experimental Medicine, 1997
- Interleukin‐5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c miceImmunology & Cell Biology, 1997
- Th1 and Th2 cytokine induction in pulmonary T cells during infection with respiratory syncytial virusJournal of General Virology, 1996